Vimarsana
Biggest News Aggregation in the World

On Going Phase News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from On Going Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In On Going Phase Today - Breaking & Trending Today

Cassava Sciences Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 Trials - Vimarsana News

Cassava Sciences Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 Trials

An Independent Data and Safety Monitoring Board Recently Evaluated the Interim Patient Safety Database for Oral Simufilam in On-going Phase 3 Trials. The DSMB Recommended Both Phase 3 Trials...

Cassava Sciences Announces Positive Interim Safety Review of Simufilam On-going Phase 3 Trials in Patients with Alzheimer's Disease - Vimarsana News

Cassava Sciences Announces Positive Interim Safety Review of Simufilam On-going Phase 3 Trials in Patients with Alzheimer's Disease

An Independent Data and Safety Monitoring Board Recently Evaluated the Interim Patient Safety Database for Simufilam in On-Going Phase 3 Clinical Trials.The DSMB Recommended the Phase 3 Trials of...

Cassava Sciences Announces Positive Interim Safety Review - Vimarsana News

Cassava Sciences Announces Positive Interim Safety Review

An Independent Data and Safety Monitoring Board (DSMB) Recently Evaluated the Interim Patient Safety Database for Simufilam in On-Going Phase 3 Clinical...

Cassava Sciences Announces Completion of Dosing in - Vimarsana News

Cassava Sciences Announces Completion of Dosing in

Outside Biostatisticians with Specific Expertise in Alzheimer’s Disease Will Conduct an Independent Statistical Analysis on The Clinical Dataset. Clinical...

Cassava Sciences Announces Initiation of an Open-label - Vimarsana News

Cassava Sciences Announces Initiation of an Open-label

Alzheimer’s Patients Who Complete Participation in a Phase 3 Study of Simufilam are Eligible to Enroll52-week Study of Simufilam 100 mgUp to 1,600 Patients...